Tag Archives: IL-6

MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls

Posted on 04/20/2020 by wames

MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls, by Nina Groven, Egil Andreas Fors, Astrid Kamilla Stunes, Solveig Klæbo Reitan in Brain, Behavior, & Immunity – Health Vol … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off on MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls

Effects of telephone-delivered cognitive behavioral stress management intervention in CFS

Posted on 08/05/2016 by wames

Research abstract: The perceived impact of chronic fatigue on daily living (i.e., fatigue interference) is particularly relevant for patients diagnosed with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), a medically unexplained illness associated with neuroendocrine and immune abnormalities. Literature suggests that fatigue … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Effects of telephone-delivered cognitive behavioral stress management intervention in CFS

Interleukin-6 levels at rest and in response to exercise

Posted on 12/10/2014 by wames

Research abstract IL-6 plays a mechanistic role in conditions such as metabolic syndrome, chronic fatigue syndrome and clinical depression and also plays a major role in inflammatory and immune responses to exercise. The purpose of this study was to investigate … Continue reading →

Posted in News | Tagged , , | Comments Off on Interleukin-6 levels at rest and in response to exercise